Strategy (MSTR) Stock Could Be 21.3% Below Fair Value After $100 Million Bitcoin Buy

Strategy (MSTR) is back in focus after buying 1,587 Bitcoin for about US$100 million, using common stock sales that also lifted cash reserves and renewed debate around dilution and long term value.

See our latest analysis for Strategy.

Despite the latest Bitcoin purchase, Strategy’s 30 day share price return is down 26.3% and the year to date share price return is down 21.9%. However, the 3 year total shareholder return is more than triple, suggesting long term momentum has been strong even as shorter term sentiment has weakened.

If this kind of volatility has you looking beyond a single Bitcoin proxy, it could be a useful moment to broaden your search using the 20 cryptocurrency and blockchain stocks

So with Strategy stock trading well below analyst targets, yet carrying sizeable Bitcoin holdings, preferred obligations and recent share issuance, is the current weakness an opening for investors, or is the market already pricing in future growth?

Advertisement

Preferred Price to Book Multiple of 1.2x: Is it justified?

On recent numbers, Strategy stock is trading at a P/B of 1.2x, which screens as inexpensive against both its own peer set and the wider US software sector.

P/B compares the market value of the equity to the accounting value of net assets, so it is often used for asset heavy or balance sheet focused companies. For Strategy, which holds substantial Bitcoin and has preferred obligations funded entirely by higher risk external borrowing, a lower P/B can indicate that the market is cautious about the quality or earnings power of those assets rather than the raw book value alone.

Relative to peers, the discount is clear. Strategy’s 1.2x P/B is well below the peer average of 5.6x and also below the US software industry average of 3x. This suggests the market is assigning a materially lower multiple to its equity than to other software companies with similar book values. That gap may reflect its current losses, reliance on external funding and the volatility associated with Bitcoin exposure.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-book of 1.2x (UNDERVALUED)

However, Strategy’s reliance on Bitcoin exposure and preferred obligations funded by higher risk external borrowing could quickly change sentiment if funding costs or crypto prices move against it.

Find out about the key risks to this Strategy narrative.

Another View: What Does the SWS DCF Model Say About Strategy Stock?

The book value argument says Strategy stock looks inexpensive, but the SWS DCF model also points to upside, with an estimated fair value of $155.99 versus the current $122.81. That is a 21.3% discount. How much faith should you place in long range cash flow estimates?

Look into how the SWS DCF model arrives at its fair value.

MSTR Discounted Cash Flow as at Jun 2026
MSTR Discounted Cash Flow as at Jun 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Strategy for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of risks and rewards around Strategy has you undecided, take a moment to review the full picture for yourself and weigh both sides with the 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond Strategy stock?

If Strategy has sharpened your focus on risk, reward and valuation, do not stop here; use fresh stock ideas to keep your portfolio options open.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:MSTR

Strategy

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0